SRSwarnendu Roy

Swarnendu Roy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Swarnendu Roy has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecular Basis of Ionic Suppression of ZAP-70 Dependent T Cell Receptor Activation

    by Swarnendu Roy, Soumee SenGupta, Kaustav Gangopadhyay, Jibitesh Das, Anushka Sinha, Sudipta Majumder, Prosad Kumar Das, Manas Pratim Chakraborty, Samiran Mondal, Bidisha Sinha, et al.

    Ionic imbalance in the tumor microenvironment alters the tumor-infiltrating T lymphocyte function. High extracellular K + suppresses T cell function by negatively regulating T cell receptor (TCR) signaling. In contrast, elevated extracellular Na + enhances T cell effector function by boosting the phosphorylation of TCR signaling modules. Here, we presented a mechanism explaining how the two monovalent cations differently regulate TCR function. At rest, high intracellular K + uncouples allosteric recruitment of ZAP-70, a key signaling module, to the TCR complex. The formation of antigen TCR complex induces K + efflux, causing spontaneous recruitment of ZAP-70 to the TCR. Increasing extracellular K + perturbs K + efflux and slows ZAP-70 recruitment to the TCR complex, even upon antigen binding. This leads to defects in T cell development and arthritis-like symptoms in juvenile mice. We conclude that K + dynamics is integral to T cell ligand discrimination and fundamental to turning off the signaling during T cell quiescence.

  • Open Access

    E41K Mutation Activates Bruton’s Tyrosine Kinase by Stabilizing an Inositol Hexakisphosphate dependent Invisible Dimer

    by Subhankar Chowdhury, Manas Pratim Chakraborty, Swarnendu Roy, Kaustav Gangopadhyay, Rahul Das

    Bruton’s tyrosine kinase (BTK) regulates diverse cellular signaling of the innate and adaptive immune system in response to microbial pathogens. Downregulation or constitutive activation of BTK is reported in patients with autoimmune diseases or various B-cell leukemias. BTK is a multidomain protein tyrosine kinase that adopts an Src-like autoinhibited conformation maintained by the interaction between the kinase and PH-TH domains. The PH-TH domain plays a central role in regulating BTK function. The BTK is activated by binding to PIP 3 at the plasma membrane upon stimulation by the B-cell receptor (BCR). The PIP 3 binding allows dimerization of the PH-TH domain and subsequent transphosphorylation of the activation loop. Alternatively, a recent study shows that the multivalent T-cell-independent (TI) antigen induces BCR response by activating BTK independently of PIP 3 binding. It was proposed that a transiently stable IP 6 -dependent PH-TH dimer may activate BTK during BCR activation by the TI antigens. However, no IP6-dependent PH-TH dimer has been identified yet. Here, we investigated a constitutively active PH-TH mutant (E41K) to determine if the elusive IP 6 -dependent PH-TH dimer exists. We showed that the constitutively active E41K mutation activates BTK by stabilizing the IP 6 -dependent PH-TH dimer. We observed that a downregulating mutation in the PH-TH domain (R28H) linked to X-linked agammaglobulinemia impairs BTK activation at the membrane and in the cytosol by preventing PH-TH dimerization. We conclude that the IP 6 dynamically remodels the BTK active fraction between the membrane and cytoplasm. Stimulating with IP 6 increases the cytosolic fraction of the activated BTK.